Arkansas Legal Resource Navigator

21 U.S.C. § 350b — New dietary ingredients

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 350b — New dietary ingredients

Page 132 TITLE 21—FOOD AND DRUGS § 350b 301 et seq.), during the 90-day period beginning on December 29, 2022, an individual may, with- out prior notice to the Food and Drug Admin- istration, import up to a 3-month supply of in- fant formula for personal use from— (A) Canada; (B) any country in the European Union; or (C) any other country that is determined by the Secretary to be implementing and en- forcing requirements for infant formula that provide a similar assurance of safety and nu- tritional adequacy as the requirements of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). (2) Limitations Infant formula may be imported pursuant to paragraph (1) only if the infant formula— (A) is exclusively for personal use and will not be commercialized or promoted; and (B) does not present an unreasonable risk to human health. (3) Reporting of adverse events If a health care provider becomes aware of any adverse event which the health care pro- vider reasonably suspects to be associated with infant formula imported pursuant to paragraph (1), the health care provider shall report such adverse event to the Commis- sioner of Food and Drugs. (4) Public notice The Secretary, acting through the Commis- sioner of Food and Drugs, shall post on the public website of the Food and Drug Adminis- tration notice that— (A) infant formula imported pursuant to paragraph (1) may not have been manufac- tured in a facility that has been inspected by the Food and Drug Administration; (B) the labeling of such infant formula may not meet the standards and other re- quirements applicable with respect to infant formula under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.); and (C) the nutritional content of infant for- mula imported pursuan

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 350b

Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 19083015599017a83849fb6a2e9654e6382825edc0b4784d2a0715d60d317500. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:usc2024-088a405d9e9e005a6ed9a4d5
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-350b-new-dietary-ingredients--30648c3341.md
Pages: Not recorded – Not recorded
Passage SHA-256: 69bc10183d4cd5867625bb76230bb8aa4cb8ddaf5f9d328d0f216648b9cfcf3a

Source location: USCODE-2024-title21-chap9-subchapIV-sec350b.pdf

Stored source content

Page 132 TITLE 21—FOOD AND DRUGS § 350b 301 et seq.), during the 90-day period beginning on December 29, 2022, an individual may, with- out prior notice to the Food and Drug Admin- istration, import up to a 3-month supply of in- fant formula for personal use from— (A) Canada; (B) any country in the European Union; or (C) any other country that is determined by the Secretary to be implementing and en- forcing requirements for infant formula that provide a similar assurance of safety and nu- tritional adequacy as the requirements of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). (2) Limitations Infant formula may be imported pursuant to paragraph (1) only if the infant formula— (A) is exclusively for personal use and will not be commercialized or promoted; and (B) does not present an unreasonable risk to human health. (3) Reporting of adverse events If a health care provider becomes aware of any adverse event which the health care pro- vider reasonably suspects to be associated with infant formula imported pursuant to paragraph (1), the health care provider shall report such adverse event to the Commis- sioner of Food and Drugs. (4) Public notice The Secretary, acting through the Commis- sioner of Food and Drugs, shall post on the public website of the Food and Drug Adminis- tration notice that— (A) infant formula imported pursuant to paragraph (1) may not have been manufac- tured in a facility that has been inspected by the Food and Drug Administration; (B) the labeling of such infant formula may not meet the standards and other re- quirements applicable with respect to infant formula under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.); and (C) the nutritional content of infant for- mula imported pursuant to paragraph (1) may vary from that of infant formula meet- ing such standards and other requirements. (5) Sense of Congress It is the sense of Congress that persons con- sidering the personal importation of infant formula should consult with their pediatrician about such importation. (Pub. L. 117–328, div. FF, title III, § 3401, Dec. 29, 2022, 136 Stat. 5838.) Editorial Notes REFERENCES IN TEXT The Federal Food, Drug, and Cosmetic Act, referred to in subsec. (m)(1), (4)(B), is act June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to chapter 9 (§ 301 et seq.) of this title. For complete classification of this Act to the Code, see section 301 of this title and Tables. CODIFICATION Section was enacted as part of the Food and Drug Omnibus Reform Act of 2022, and not as part of the Fed- eral Food, Drug, and Cosmetic Act which comprises this chapter. Section is comprised of section 3401 of div. FF of Pub. L. 117–328. Subsec. (a)(2) of section 3401 of div. FF of Pub. L. 117–328 amended section 321 of this title. Sub- secs. (c), (g)(1)–(4), (6), and (l) of such section 3401 amended section 350a of this title. Subsec. (k) of such section 3401 enacted section 350m of this title. Statutory Notes and Related Subsidiaries DEFINITION OF ‘‘SECRETARY’’ Pub. L. 117–328, div. FF, title III, § 3002, Dec. 29, 2022, 136 Stat. 5807, provided that: ‘‘In this title [see Short Title of 2022 Amendment note set out under section 301 of this title], except as otherwise specified, the term ‘Secretary’ means the Secretary of Health and Human Services.’’ § 350b. New dietary ingredients (a) In general A dietary supplement which contains a new di- etary ingredient shall be deemed adulterated under section 342(f) of this title unless it meets one of the following requirements: (1) The dietary supplement contains only di- etary ingredients which have been present in the food supply as an article used for food in a form in which the food has not been chemi- cally altered. (2) There is a history of use or other evi- dence of safety establishing that the dietary ingredient when used under the conditions rec- ommended or suggested in the labeling of the dietary supplement will reasonably be ex- pected to be safe and, at least 75 days before being introduced or delivered for introduction into interstate commerce, the manufacturer or distributor of the dietary ingredient or die- tary supplement provides the Secretary with information, including any citation to pub- lished articles, which is the basis on which the manufacturer or distributor has concluded that a dietary supplement containing such di- etary ingredient will reasonably be expected to be safe. The Secretary shall keep confidential any infor- mation provided under paragraph (2) for 90 days following its receipt. After the expiration of such 90 days, the Secretary shall place such in- formation on public display, except matters in the information which are trade secrets or oth- erwise confidential, commercial information. (b) Petition Any person may file with the Secretary a peti- tion proposing the issuance of an order pre- scribing the conditions under which a new die- tary ingredient under its intended conditions of use will reasonably be expected to be safe. The Secretary shall make a decision on such petition within 180 days of the date the petition is filed with the Secretary. For purposes of chapter 7 of title 5, the decision of the Secretary shall be considered final agency action. (c) Notification (1) In general If the Secretary determines that the infor- mation in a new dietary ingredient notifica- tion submitted under this section for an arti- cle purported to be a new dietary ingredient is inadequate to establish that a dietary supple- ment containing such article will reasonably Page 133 TITLE 21—FOOD AND DRUGS § 350c be expected to be safe because the article may be, or may contain, an anabolic steroid or an analogue of an anabolic steroid, the Secretary shall notify the Drug Enforcement Adminis- tration of such determination. Such notifica- tion by the Secretary shall include, at a min- imum, the name of the dietary supplement or article, the name of the person or persons who marketed the product or made the submission of information regarding the article to the Secretary under this section, and any contact information for such person or persons that the Secretary has. (2) Definitions For purposes of this subsection— (A) the term ‘‘anabolic steroid’’ has the meaning given such term in section 802(41) of this title; and (B) the term ‘‘analogue of an anabolic ster- oid’’ means a substance whose chemical structure is substantially similar to the chemical structure of an anabolic steroid. (d) ‘‘New dietary ingredient’’ defined For purposes of this section, the term ‘‘new di- etary ingredient’’ means a dietary ingredient that was not marketed in the United States be- fore October 15, 1994 and does not include any di- etary ingredient which was marketed in the United States before October 15, 1994. (June 25, 1938, ch. 675, § 413, as added Pub. L. 103–417, § 8, Oct. 25, 1994, 108 Stat. 4331; amended Pub. L. 111–353, title I, § 113(a), Jan. 4, 2011, 124 Stat. 3920.) Editorial Notes AMENDMENTS 2011—Subsecs. (c), (d). Pub. L. 111–353 added subsec. (c) and redesignated former subsec. (c) as (d). Statutory Notes and Related Subsidiaries GUIDANCE Pub. L. 111–353, title I, § 113(b), Jan. 4, 2011, 124 Stat. 3921, provided that: ‘‘Not later than 180 days after the date of enactment of this Act [Jan. 4, 2011], the Sec- retary shall publish guidance that clarifies when a die- tary supplement ingredient is a new dietary ingredient, when the manufacturer or distributor of a dietary in- gredient or dietary supplement should provide the Sec- retary with information as described in section 413(a)(2) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 350b(a)(2)], the evidence needed to document the safety of new dietary ingredients, and appropriate methods for establishing the identify [sic] of a new dietary ingre- dient.’’ CONSTRUCTION OF 2011 AMENDMENT Nothing in amendment by Pub. L. 111–353 to be con- strued to apply to certain alcohol-related facilities, to alter jurisdiction and authorities established under cer- tain other Acts, or in a manner inconsistent with inter- national agreements to which the United States is a party, see sections 2206, 2251, and 2252 of this title. § 350c. Maintenance and inspection of records (a) Records inspection (1) Adulterated food If the Secretary has a reasonable belief that an article of food, and any other article of food that the Secretary reasonably believes is like- ly to be affected in a similar manner, is adul- terated and presents a threat of serious ad- verse health consequences or death to humans or animals, each person (excluding farms and restaurants) who manufactures, processes, packs, distributes, receives, holds, or imports such article shall, at the request of an officer or employee duly designated by the Secretary, permit such officer or employee, upon presen- tation of appropriate credentials and a written notice to such person, at reasonable times and within reasonable limits and in a reasonable manner, to have access to and copy all records relating to such article, and to any other arti- cle of food that the Secretary reasonably be- lieves is likely to be affected in a similar man- ner, that are needed to assist the Secretary in determining whether the food is adulterated and presents a threat of serious adverse health consequences or death to humans or animals. (2) Use of or exposure to food of concern If the Secretary believes that there is a rea- sonable probability that the use of or exposure to an article of food, and any other article of food that the Secretary reasonably believes is likely to be affected in a similar manner, will cause serious adverse health consequences or death to humans or animals, each person (ex- cluding farms and restaurants) who manufac- tures, processes, packs, distributes, receives, holds, or imports such article shall, at the re- quest of an officer or employee duly des- ignated by the Secretary, permit such officer or employee, upon presentation of appropriate credentials and a written notice to such per- son, at reasonable times and within reasonable limits and in a reasonable manner, to have ac- cess to and copy all records relating to such article and to any other article of food that the Secretary reasonably believes is likely to be affected in a similar manner, that are need- ed to assist the Secretary in determining whether there is a reasonable probability that the use of or exposure to the food will cause serious adverse health consequences or death to humans or animals. (3) Application The requirement under paragraphs (1) and (2) applies to all records relating to the manufac- ture, processing, packing, distribution, re- ceipt, holding, or importation of such article maintained by or on behalf of such person in any format (including paper and electronic formats) and at any location. (b) Regulations concerning recordkeeping The Secretary, in consultation and coordina- tion, as appropriate, with other Federal depart- ments and agencies with responsibilities for reg- ulating food safety, may by regulation establish requirements regarding the establishment and maintenance, for not longer than two years, of records by persons (excluding farms and res- taurants) who manufacture, process, pack, transport, distribute, receive, hold, or import food, which records are needed by the Secretary for inspection to allow the Secretary to identify the immediate previous sources and the imme- diate subsequent recipients of food, including its packaging, in order to address credible threats

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 301 — Short title

This chapter may be cited as the Federal Food, Drug, and Cosmetic Act.

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 301

Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 301 — Short title

Page 30 TITLE 21—FOOD AND DRUGS § 301 Sec. 398. Notices to States regarding imported food. 399. Grants to enhance food safety. 399a. Office of the Chief Scientist. 399b. Office of Women’s Health. 399c. Improving the training of State, local, terri- torial, and tribal food safety officials. 399d. Employee protections. 399e. Nanotechnology. 399f. Ensuring adequate information regarding pharmaceuticals for all populations, par- ticularly underrepresented subpopulations, including racial subgroups. 399g. Food and Drug Administration Intercenter Institutes. 399h. National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufac- turing. 399i. Food and Drug Administration Working Cap- ital Fund. SUBCHAPTER I—SHORT TITLE § 301. Short title This chapter may be cited as the Federal Food, Drug, and Cosmetic Act. (June 25, 1938, ch. 675, § 1, 52 Stat. 1040.) Statutory Notes and Related Subsidiaries EFFECTIVE DATE; POSTPONEMENT IN CERTAIN CASES Act June 23, 1939, ch. 242, §§ 1, 2, 53 Stat. 853, 854, pro- vided that: ‘‘[SEC. 1] (a) The effective date of the following provi- sions of the Federal Food, Drug, and Cosmetic Act is hereby postponed until January 1, 1940: Sections 402(c) [342(c) of this title]; 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k) of this title]; 501(a), (4) [351(a)(4) of this title]; 502(b), (d), (e), (f), (g), and (h) [352(b), (d) to (h) of this title]; 601(e) [361(e) of this title]; and 602(b) [362(b) of this title]. ‘‘(b) The Secretary of Agriculture shall promulgate regulations further postponing to July 1, 1940[,] the ef- fective date of the provisions of sections 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k)]; 502(b), (d), (

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 301

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 350b — New dietary ingredients

**(a) In general** A dietary supplement which contains a new dietary ingredient shall be deemed adulterated under [section 342(f) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section342/f&num=0&edition=prelim) unless it meets one of the following requirements: (1) The dietary supplement contains only dietary ingredients which have been present in the food supply as an article used for food in a form in which the food has not been chemically altered. (2) There is a history of use or other evidence of safety establishing that the dietary ingredient when used under the conditions recommended or suggested in the labeling of the dietary supplement will reasonably be expected to be safe and, at least 75 days before being introduced or delivered for introduction into interstate commerce, the manufacturer or distributor of the dietary ingredient or dietary supplement provides the Secretary with information, including any citation to published articles, which is the basis on which the manufacturer or distributor has concluded that a dietary supplement containing such dietary ingredient will reasonably be expected to be safe. The Secretary shall keep confidential any information provided under paragraph (2) for 90 days following its receipt. After the expiration of such 90 days, the Secretary shall place such information on public display, except matters in the information which are trade secrets or otherwise confidential, commercial information. **(b) Petition** Any person may file with the Secretary a petition proposing the issuance of an order prescribing the conditions under which a new dietary ingredient under its intended conditions of use will reasonably be expected to be safe. The Secretary shall make a decision on such petition w

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 350b

Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.